Leomics Associates consults with organizations poised to enter the molecular diagnostic space or grow their molecular diagnostics capabilities. Founded in 2002 by Jorge Leon, Ph.D., a leader in the molecular diagnostic industry, this unique consulting group combines scientific and business expertise to offer clients the most comprehensive guidance. From introducing breakthrough technologies to advising on successful commercialization, Leomics Associates’ innovative approach stands alone.
Leomics Associates will expand the use of molecular diagnostics and personalized medicine testing via a three-pronged approach:
Decentralization: We envision in-house, hands-on use of new molecular diagnostic technologies at clinics, hospitals, and all other health care testing facilities.
Globalization: We are breaking down barriers of geography and language, creating worldwide accessibility of molecular diagnostic innovations.
Individualization: We are ensuring that diagnostic tools which address the needs for individualized drug prescription and dosage, as well as personalized prognosis, are available to all patients.